drugset / Trial / NCT00233662
Safety and Tolerability of Repeat Courses of IM Alefacept
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether repeat courses of alefacept, administered intramuscularly, are safe when given to chronic plaque psoriasis patients who are receiving standard dermatology treatments.
Timeline
- Start
- 2002-12-01
- Primary completion
- —
- Completion
- 2005-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | — | — |